Ahead Therapeutics – In the News
Ahead Therapeutics has reached an agreement with Dr. Rozen Le Panse from the Institute of Myology from Paris to stride forward with the preclinical development of AT_1616.
The agreement will allow Ahead Therapeutics to validate the platform potential of the PS-Liposomes using a Myasthenia Gravis in vivo...Read More
Ahead Therapeutics has set up a clean room facility in l'Arboç (Tarragona) to be able to produce in-house, the liposome...Read More
Ahead Therapeutics has closed an agreement with Dr. med. Ribes-Koninck from La Fe Hospital & Research institute to perform ex-vivo assays with CD patients’ samples.
Ahead Therapeutics will verify the platform potential of its PS-Liposomes with blood samples coming from Celiac Disease’s patients. Researchers from...Read More